Abstract:Background. Plasma S100A1 protein is a novel inflammatory biomarker associated with acute myocardial infarction and neurodegenerative disease's pathophysiological mechanisms. This study aimed to determine the levels of this protein in patients with acute ischemic stroke early in the disease progression and to investigate its role in the pathogenesis of acute ischemic stroke.Methods. A total of 192 participants from hospital stroke centers were collected for the study. Clinically pertinent data were recorded. The volume of the cerebral infarction was calculated according to the Pullicino formula. Multivariate logistic regression analysis was used to select independent influences. ROC curve was used to analyze the diagnostic value of AIS and TIA. The correlation between S100A1, NF -KB p65, and IL-6 levels and cerebral infarction volume was detected by Pearson correlation analysis.Results. There were statistically significant differences in S100A1, NF -KB p65, and IL-6 among the AIS,TIA, and PE groups (S100A1, [230.96 +/- 39.37] vs [185.85 +/- 43.24] vs [181.47 +/- 27.39], P < 0.001; NF -KB p65, [3.99 +/- 0.65] vs [3.58 +/- 0.74] vs [3.51 +/- 0.99], P = 0.001; IL-6, [13.32 +/- 1.57] vs [11.61 +/- 1.67] vs [11.42 +/- 2.34], P < 0.001). Multivariate logistic regression analysis showed that S100A1 might be an independent predictive factor for the diagnosis of disease (P < 0.001). The AUC of S100A1 for diagnosis of AIS was 0.818 (P < 0.001, 95% CI [0.749-0.887], cut off 181.03, J max 0.578, Se 95.0%, Sp 62.7%). The AUC of S100A1 for diagnosis of TIA was 0.720 (P = 0.001, 95% CI [0.592-0.848], cut off 150.14, J max 0.442, Se 50.0%, Sp 94.2%). There were statistically significant differences in S100A1, NF -KB p65, and IL-6 among the SCI,MCI, and LCI groups (S100A1, [223.98 +/- 40.21] vs [225.42 +/- 30.92] vs [254.25 +/- 37.07], P = 0.001; NF -KB p65, [3.88 +/- 0.66] vs [3.85 +/- 0.64] vs [4.41 +/- 0.45], P < 0.001; IL-6, [13.27 +/- 1.65] vs [12.77 +/- 1.31] vs [14.00 +/- 1.40], P = 0.007). Plasma S100A1, NF -KB p65, and IL-6 were significantly different from cerebral infarction volume (S100A1, r = 0.259, P = 0.002; NF -KB p65, r = 0.316, P < 0.001; IL-6, r = 0.177, P = 0.036). There was a positive correlation between plasma S100A1 and IL-6 with statistical significance (R = 0.353, P < 0.001). There was no significant positive correlation between plasma S100A1 and NF -KB p65 (R < 0.3), but there was statistical significance (R = 0.290, P < 0.001). There was a positive correlation between IL-6 and NF -KB p65 with statistical significance (R = 0.313, P < 0.001).Conclusion. S100A1 might have a better diagnostic efficacy for AIS and TIA. S100A1 was associated with infarct volume in AIS, and its level reflected the severity of acute cerebral infarction to a certain extent. There was a correlation between S100A1 and IL-6 and NF -KB p65, and it was reasonable to speculate that this protein might mediate the inflammatory response through the NF -KB pathway during the pathophysiology of AIS.

Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury

The Elevated Serum S100A8/A9 During Acute Myocardial Infarction Is Not of Cardiac Myocyte Origin

Receptor for Advanced Glycation End Products Involved in Circulating Endothelial Cells Release from Human Coronary Endothelial Cells Induced by C-reactive Protein

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Clinical Relevance of Cleaved RAGE Plasma Levels As a Biomarker of Disease Severity and Functional Outcome in Aneurysmal Subarachnoid Hemorrhage.

Expression of S100B during heart failure in rats

Association between serum S100B protein levels and coronary heart disease

Role of Neutrophil-Derived S100B in Acute Myocardial Infarction Patients from the Han Chinese Population.

Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children

Intra-coronary Administration of Soluble Receptor for Advanced Glycation End-Products Attenuates Cardiac Remodeling with Decreased Myocardial Transforming Growth Factor-Beta1 Expression and Fibrosis in Minipigs with Ischemia-Reperfusion Injury.

Abstract 10505: S100a12 Aggravates Acute Myocardial Infarction Injury Through Excessive Neutrophil Extracellular Trap Formation

Inflammation and Oxidative Stress Role of S100A12 as a Potential Diagnostic and Therapeutic Biomarker in Acute Myocardial Infarction

Increased Level of Soluble Syndecan-1 in Serum Correlates with Myocardial Expression in a Rat Model of Myocardial Infarction.

Increased Expression of Calcium-Sensing Receptors in Atherosclerosis Confers Hypersensitivity to Acute Myocardial Infarction in Rats

Serum acute phase reactants sCRP, SAA, IL-6 in acute coronary syndrome and its clinical significance

Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage

Diagnostic value and mechanism of plasma S100A1 protein in acute ischemic stroke: a prospective and observational study

Changes in Serum Vascular Cell Adhesion Molecules and C-reactive Protein in Patients with Acute Coronary Syndrome

S100A1 Transgenic Treatment of Acute Heart Failure Causes Proteomic Changes in Rats.

Soluble RAGE attenuates myocardial I/R injury by suppressing interleukin-6